| Literature DB >> 23112908 |
Wolfgang Gunzer1, Manuela Konrad1, Elisabeth Pail1.
Abstract
Heavily exercising endurance athletes experience extreme physiologic stress, which is associated with temporary immunodepression and higher risk of infection, particularly upper respiratory tract infections (URTI). The aim of this review is to provide a critical up-to-date review of existing evidence on the immunomodulatory potential of selected macronutrients and to evaluate their efficacy. The results of 66 placebo-controlled and/or crossover trials were compared and analysed. Among macronutrients, the most effective approach to maintain immune function in athletes is to consume ≥6% carbohydrate during prolonged exercise. Because inadequate nutrition affects almost all aspects of the immune system, a well-balanced diet is also important. Evidence of beneficial effects from other macronutrients is scarce and results are often inconsistent. Using a single nutrient may not be as effective as a mixture of several nutritional supplements. Due to limited research evidence, with the exception of carbohydrate, no explicit recommendations to reduce post-exercise URTI symptoms with single macronutrients can be derived.Entities:
Keywords: URTI; exercise-induced immunodepression; immune function ; macronutrients
Mesh:
Substances:
Year: 2012 PMID: 23112908 PMCID: PMC3475230 DOI: 10.3390/nu4091187
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Figure 1Nutrient availability and immune function: direct and indirect mechanisms. It can be inferred that a poor nutrition state may exacerbate cellular immune responses to heavy exercise and further impair immune function [47]. Adapted with permission from Walsh [32] (Solid arrows: research evidence mostly supports link; dashed arrow: limited research evidence to support link in athletes; ↑: increase; ↓: decrease).
Effects of pre-exercise high- vs. low-CHO diet on hormonal & immune response to endurance exercise (↑: increase; ↓: decrease; ↔: no effect; CHO: carbohydrate; BW: bodyweight; /day: per day).
| Hormonal/Immune Response | High-CHO Diet (70%–77% Dietary Intake from CHO/8.0–12.0 g CHO/kg BW/day) | Low-CHO Diet/Self Selected (7%–11% Dietary Intake from CHO/0.5 g CHO/kg BW/day) | |
|---|---|---|---|
| Glucose response | ↑ Glucose response [ | ↓ Low blood glucose level [ | |
| Glutamine level | ↑ Glutamine level [ | ↓ Glutamine level [ | |
| Cortisol response | ↓ Plasma cortisol [51,53,58] | ↑ Plasma or salivary cortisol [ | |
| Leukocyte & lymphocyte cell counts | ↔ Circulating leukocytes [ | ↑ Numbers of neutrophils [ | |
| ↓ Numbers of neutrophils [ | |||
| ↑ Neutrophil:lymphocyte ratio [ | |||
| ↔ Post-exercise lymphocytopenia [ | |||
| Mucosal immunity | ↑ Post-exercise s-IgA concentration than pre-exercise [ | ||
| Cytokine response | ↑ IL-6, IL-10, IL-1ra [ |
Effects of CHO supplementation during exercise on selected immune variables relative to control. (↑: significant increase; ↓: significant decrease; ↔: no difference; -: not tested/not accessible; post: post-exercise; Wmax: maximal power; TT: time trial; PLA: control group; Ref.: Reference).
| Ref. | Mode | Intensity | CHO dose | Leukocytes | Lymphocytes | Neutrophils | NK Cells | Cytokines | Mucosal Immunity | Cortisol | Blood Glucose | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| [ | 2.5 h running | 77% VO2max | 6% | - | - | - | - | ↓ IL-6 post, post 1.5 h | - | ↓ post | ↑ post | |
| ↓ IL-1ra post 1.5 h | ||||||||||||
| [ | 2.5 h running | 77% VO2max | 6% every 15 min | ↓ (monocytes) post | ↓ post | ↓ post | - | - | - | ↓ post | ↑ post | |
| ↑ post 3 h | ↓ post 1.5 h | |||||||||||
| [ | 2.5 h running | 77% VO2max | 6% every 15 min | ↓ post | - | - | ↓ post | ↑ post | ||||
| ↔ NKCA | ||||||||||||
| [ | 2.5 h running or cycling | 75% VO2max | 6% every 15 min | ↓ (monocytes) post | - | ↓ post | - | - | - | ↓ post | ↑ post | |
| [ | 2.5 h running or cycling | 75% VO2max | 6% | - | ↓ post-exercise lymphocytosis | - | ↓ NKCA | - | - | ↓ post (cycling & running) | ↑ post | |
| [ | 2 h cycling | 60% VO2max | 6% | - | - | - | - | - | ↓ s-IgA concent-ration during exercise | - | ↑ post | |
| [ | 2 h rowing | - | - | ↓ (monocytes) post | - | ↓ post | - | ↓ IL-1ra post | - | ↔ | ↑ post | |
| ↔ IL-6 post | ||||||||||||
| ↔ IL-8 post | ||||||||||||
| ↔ TNF-α | ||||||||||||
| [ | 1 h cycling and running | At individual’s lactate threshold | 6.4% 12 mL/kg BW | - | - | - | - | ↓ IL-6 post in cycling & running | - | - | ↑ post | |
| [ | Marathon run | - | 6% | - | - | - | - | ↓ IL-10 post | - | ↓ post | ↑ post | |
| ↓ IL-1ra post | ||||||||||||
| ↔ IL-6 post | ||||||||||||
| ↑ IL-8 post | ||||||||||||
| [ | 6 × 20 min cycling | 90% of individual’s lactate threshold | 1 g/kg BW/h (10%) | - | - | - | - | ↓ cytokine response post | - | ↓ post | ↑ post | |
| [ | 6 × 15 min intermittent running | - | Every 15 min | - | - | ↓ post 30 min | - | ↓ IL-6 post 30 min | - | ↓ post 30 min | ↑ post | |
| ↔ TNF-α post | ||||||||||||
| [ | 3 h run | 70% VO2max | 6% every 15 min | ↓ post | ↓ post | - | - | ↓ IL-6 post | ↔ | ↓ post | ↑ post | |
| ↓ IL-10 post | ||||||||||||
| ↓ IL-1ra post | ||||||||||||
| ↔ IL-8 post | ||||||||||||
| [ | 2 h cycling | - | 6.4% | - | - | - | - | ↓ IL-6 post | - | - | ↑ post | |
| ↓ muscle derived IL-6 post | ||||||||||||
| [ | 2 h cycling | 75% VO2max | 6.4% | - | - | ↓ post | - | - | - | ↓ post | ↑ post | |
| ↓ post 1 h | ||||||||||||
| [ | 2.5 h cycling | 85% VO2max | 6% | ↓ post | ↔ | ↓ post | - | - | - | ↓ post | ↑ post | |
| ↓ post 1 h | ↓ post 1 h | ↓ post 1 h | ||||||||||
| [ | Marathon run | - | 6% | ↓ (monocytes) post | ↔ on post lymphocytopenia | ↓ post | ↔ | ↔ cytokine response post | - | ↓ post | ↑ post | |
| [ | 2 × 1 h cycling | 75%–80% VO2max | 60 g/h | - | ↔ | - | ↔ | - | - | - | ↑ post | |
| [ | 1 h cycling | 70% VO2max | 6% | - | ↓ post | ↓ post | ↓ post | ↔ IL-6 post | - | -. | ↑ post | |
| ↓ post 1 h | ↔ TNF-α post | |||||||||||
| [ | 2.5 h cycling | 60% Wmax | 6% | - | - | - | - | ↓ IL-6 post | - | ↓ post | ↑ post | |
| ↓ IL-10 post | ||||||||||||
| ↓ IL-1ra post | ||||||||||||
| ↔ IL-8 post | ||||||||||||
| ↔ muscle IL-6, IL-8, TNF-α post | ||||||||||||
| [ | 2 × 1.5 h cycling | 60% VO2max | 10% | - | - | - | - | - | ↔ | ↓ post | ↑ post | |
| [ | 2.5 h cycling | 65% VO2max | 6.4%12.8% | ↓ post in 6.4% + 12.8% | ↓ post in 6.4% + 12.8% (T-cell subpopulations) | ↓ post in 6.4% + 12.8% | - | - | - | ↓ post in 6.4% + 12.8% | ↑ post in 6.4% + 12.8% | |
| ↓ post 2 h in 6.4% + 12.8% | ↓ post 2 h in 6.4% + 12.8% | |||||||||||
| ↓ post 2 h in 6.4% + 12.8% | ||||||||||||
| ↔ between 6.4% + 12.8% | ↔ between 6.4% + 12.8% | |||||||||||
| ↔ between 6.4% + 12.8% | ||||||||||||
| [ | 1.5 h running on two consecutive days | 70%–80% VO2max | 6.4% | ↓ total count (D1 + D2) | ND (D1 + D2) but ↓ T-cell count post (D1 + D2) | ↓ post (D1 + D2) | ↔ | - | - | ↔ (D1 + D2) | ↑ post (D1 + D2) | |
| ↓ (monocytes) post (D1) | ||||||||||||
| ↓ post 1 h (D1 + D2) | ||||||||||||
| DAY1 (D1) | ↓ (monocytes) post 1 h (D1 + D2) | |||||||||||
| DAY2 (D2) | ||||||||||||
| [ | 4 h cycling | 70% of individual anaerobic threshold | 6%12% | ↓ post in 6% + 12% | ↔ but trend to attenuate lymphocytopenia in 6% + 12% post 1 h | ↓ post in 6% + 12% | ↔ | ↓ IL-6 post in 6% + 12% | - | ↓ post in 6% + 12% | ↑ post in 6% + 12% | |
| ↓ IL-6 post 1 h in 6% + 12% | ↓ post 1 h in 6% + 12% | |||||||||||
| ↓ post 1 h in 6% + 12% | ||||||||||||
| ↔ between 6% + 12% | ↓ post 1 h in 6% + 12% | |||||||||||
| ↔ between 6% + 12% | ||||||||||||
| ↔ between 6% + 12% | ↔ between 6% + 12% | |||||||||||
| [ | 2 h cycling | 64% Wmax | 6% every 15 min | ↓ (monocytes) post | ↔ | ↓ post | ↔ | - | - | ↓ post | ↑ post | |
| [ | Duathlon (5 km run—20 km cycling—2.5 km run) | - | 6% malto-dextrin | - | - | - | - | - | - | ↓ post | ↑ post | |
| [ | 2 h cycling | 65% VO2max | 6% CHO | ↓ post in experimental conditions with CHO | ↓ post in experimental conditions with CHO | ↓ post in experimental conditions with CHO | - | - | - | ↓ post in CHO/PLA condition | ↑ post in experimental conditions with CHO | |
| 6 mg/kg BW caff eine (CAF) | ↓ post 1 h in experimental conditions with CHO | ↓ post 1 h in experimental conditions with CHO | ||||||||||
| ↔ in CHO/CAF | ||||||||||||
| [ | 1.5 h cycling followed by 16 km TT | - | 0,24 g/kg BW CHO gel every 15 min | ↓ (monocytes) post | ↔ | ↓ post | - | ↔ IL-6 post | - | ↔ | ↑ post | |
| ↔ IL-10 post | ||||||||||||
| ↔ IL-1ra post | ||||||||||||
| ↔ IL-8 post | ||||||||||||
| [ | 1.5 h TT running | - | 8% | - | - | - | - | ↓ IL-6 post | - | - | ↑ post | |
| [ | 2 h run, followed by 5 km TT | 60% VO2max | 8% | - | - | - | - | ↓ IL-6 post | - | - | ↑ post |
Immunomodulating nutritional strategies & countermeasures: evidence and likely impact (CHO: carbohydrate; BCAA: branched chain amino acid; n-3 PUFA: Omega-3 polyunsaturated fatty acids; evidence for rationale: −: no evidence; +: very limited evidence exists—more research is needed; ++: limited evidence exists—more research is needed; +++: relatively strong evidence; ++++: strong evidence; likely impact: −: no influence; +: very limited influence; ++: limited influence; +++: relatively strong influence; ++++: strong influence).
| Nutrient/Strategy | Rationale | Evidence | Likely Impact |
|---|---|---|---|
| Adequate nutrient availability (e.g., micronutrients, fluid) | Adequate nutrient availability maintains immunocompetence | ++++ | ++++ |
| High-CHO diet | Maintained blood glucose level → lower stress hormone levels → attenuated post-ex immune response | ++ | ++ |
| CHO ingestion during exercise | Maintained blood glucose level → lower stress hormone levels → attenuated post-ex immune response | +++ | +++ |
| CHO ingestion post-exercise | Attenuating effect on some immune variables (prevents lymphocytopenia, faster IL-6 return to pre-exercise level) during recovery | − | − |
| Dietary protein availability | Protein is needed for production of immune variables | ++ | ++ |
| Glutamine | Glutamine hypothesis; protein synthesis | − | + |
| BCAA | Precursors of glutamine | ++ | + |
| Creatine | Muscle trauma from heavy exercise → higher inflammatory markers (TNF-α, prostaglandin). | + | + |
| Creatine prevents muscle trauma → attenuated inflammation markers | |||
| Cystine/theanine | Reinforced glutathione synthesis → reinforced anti-oxidative response & better immune function | + | + |
| Dietary fat intake | Low-fat: energy & micronutrient deficiency | ++ | ++ |
| High-fat: excessive intake at cost of protein/CHO | |||
| Anti-inflammatory effects of | − | − |